These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief. Pasquinucci L; Parenti C; Georgoussi Z; Reina L; Tomarchio E; Turnaturi R Molecules; 2021 Jul; 26(14):. PubMed ID: 34299443 [TBL] [Abstract][Full Text] [Related]
4. In vivo trafficking of endogenous opioid receptors. Wang Y; Van Bockstaele EJ; Liu-Chen LY Life Sci; 2008 Nov; 83(21-22):693-9. PubMed ID: 18930741 [TBL] [Abstract][Full Text] [Related]
6. Chronification of Pain: Mechanisms, Current Understanding, and Clinical Implications. Pak DJ; Yong RJ; Kaye AD; Urman RD Curr Pain Headache Rep; 2018 Feb; 22(2):9. PubMed ID: 29404791 [TBL] [Abstract][Full Text] [Related]
7. Study on the molecular mechanism of antinociception induced by ghrelin in acute pain in mice. Liu FY; Zhang MM; Zeng P; Liu WW; Wang JL; Yang B; Dai Q; Wei J Peptides; 2016 Sep; 83():1-7. PubMed ID: 27474249 [TBL] [Abstract][Full Text] [Related]
8. Delta opioid receptor-mediated analgesia is not altered in preprotachykinin A knockout mice. Dubois D; Gendron L Eur J Neurosci; 2010 Dec; 32(11):1921-9. PubMed ID: 21044181 [TBL] [Abstract][Full Text] [Related]
9. Discovery and development of tramadol for the treatment of pain. Bravo L; Mico JA; Berrocoso E Expert Opin Drug Discov; 2017 Dec; 12(12):1281-1291. PubMed ID: 28920461 [TBL] [Abstract][Full Text] [Related]
10. Preclinical assessment of utility of M6S for multimodal acute and chronic pain treatment in diabetic neuropathy. Yadlapalli JSK; Dogra N; Walbaum AW; Prather PL; Crooks PA; Dobretsov M Life Sci; 2018 Jan; 192():151-159. PubMed ID: 29191644 [TBL] [Abstract][Full Text] [Related]
11. Molecular Pharmacology of δ-Opioid Receptors. Gendron L; Cahill CM; von Zastrow M; Schiller PW; Pineyro G Pharmacol Rev; 2016 Jul; 68(3):631-700. PubMed ID: 27343248 [TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor-induced emergence of synaptic δ-opioid receptors and behavioral antinociception in persistent neuropathic pain. Tao W; Zhou W; Wang Y; Sun T; Wang H; Zhang Z; Jin Y Neuroscience; 2016 Dec; 339():54-63. PubMed ID: 27646288 [TBL] [Abstract][Full Text] [Related]
14. Unique pharmacology of tapentadol for treating acute and chronic pain. Knezevic NN; Tverdohleb T; Knezevic I; Candido KD Expert Opin Drug Metab Toxicol; 2015; 11(9):1475-92. PubMed ID: 26215077 [TBL] [Abstract][Full Text] [Related]
15. Antinociception induced by a novel α Sudo RT; do Amaral RV; Monteiro CEDS; Pitta IDR; Lima MDC; Montes GC; Ririe DG; Hayashida K; Zapata-Sudo G Eur J Pharmacol; 2017 Nov; 815():210-218. PubMed ID: 28935564 [TBL] [Abstract][Full Text] [Related]
17. A piece of the puzzle is revealed for delta opioid receptor-mediated analgesia. Cahill CM; Taylor A Pain; 2011 Jun; 152(6):1217-1218. PubMed ID: 21333447 [No Abstract] [Full Text] [Related]
18. The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain. Tsukahara-Ohsumi Y; Tsuji F; Niwa M; Hata T; Narita M; Suzuki T; Sasano M; Aono H Eur J Pharmacol; 2011 Dec; 671(1-3):53-60. PubMed ID: 21970808 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse. Jinsmaa Y; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Okada Y; Ambo A; Sasaki Y; Bryant SD; Lazarus LH Eur J Pharmacol; 2005 Feb; 509(1):37-42. PubMed ID: 15713427 [TBL] [Abstract][Full Text] [Related]
20. The role of nitric oxide in the local antiallodynic and antihyperalgesic effects and expression of delta-opioid and cannabinoid-2 receptors during neuropathic pain in mice. Hervera A; Negrete R; Leánez S; Martín-Campos J; Pol O J Pharmacol Exp Ther; 2010 Sep; 334(3):887-96. PubMed ID: 20498253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]